A phase I/II dose ranging study of DUROS (TM) (leuprolide) implantable therapeutic system in patients with advanced prostate cancer
1998
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
0
References
5
Citations
NaN
KQI